Health and Healthcare

Tuesday's Top Biotech and Medical Stocks

From BioHealth Investor

Biotechnology

NEURALSTEM INC [NRLS.OB] +19.05%
REPROS THERAPEUTICS [RPRX] +16.52%
CYTORI THERAPEUTICS [CYTX] +13.83%
ADVENTRX PHARMACTL [ANX] +10.98%
ARTES MEDICAL, INC. [ARTE] +9.83%

Diagnostic Substances

ASPENBIO PHARMA INC [APNB.OB] +7.66%
EPICEPT CORPORATION [EPCT] +7.19%
ISTA PHARMACTLS [ISTA] +6.54%
THRESHOLD PHARMACEUT [THLD] +5.08%
TORREYPINES THERAPEU [TPTX] +4.69%

Drug Delivery

IOMED INC [IOX] +3.67%
COLUMBIA LABS INC [CBRX] +2.78%
MATRIXX INITIATVS [MTXX] +1.91%
BIOVAIL CORP [BVF] +1.89%
NOVADEL PHARMA INC [NVD] +1.84%

Drug Manufacturers

QUICK-MED TECHNOLOG [QMDT.OB] +20.19%
JAVELIN PHARMACEUTIC [JAV] +11.83%
NITROMED, INC. [NTMD] +5.04%
DUSA PHARM INC [DUSA] +3.55%
BRADLEY PHARMACTCL [BDY] +3.25%

Medical Appliances & Equipment

ESCALON MED CP [ESMC] +7.36%
RESTORE MEDICAL INC [REST] +5.05%
SYMMETRY MEDICAL INC [SMA] +4.81%
SPECTRASCIENCE NEW [SCIE.OB] +4.48%
INVACARE CORP [IVC] +3.47%

Medical Instruments & Supplies

MINDRAY MEDICAL INTL [MR] +6.63%
ENDOLOGIX INC [ELGX] +5.67%
ENPATH MED INC [NPTH] +5.38%
MEMRY CORPORATION [MRY] +4.84%
RETRACTABLE TECH INC [RVP] +3.99%

Medical Laboratories & Research

PREMD INC [PME] +6.08%
BIO-IMAGING TECH [BITI] +2.21%
ALLIANCE IMAGING INC [AIQ] +2.15%
NEOGENOMICS INC [NGNM.OB] +2.07%
SPHERIX INC [SPEX] +2.00%

http://biohealthinvestor.com/

Sponsored: Want to Retire Early? Here’s a Great First Step

Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?

Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.

Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.